LLY Stock to Benefit From Market Dominance Eli Lillys key growth driver remains its incretin franchise, led by Mounjaro and Zepbound
Inhibitory effect of glucagon-like peptide-1 on small bowel motility
Gastroparesis is delayed gastric emptying in the absence of mechanical obstruction, lasting at least 3 months, causing nausea, vomiting, bloating, early satiety, and abdominal pain
While fiber is essential, consuming large volumes of high-fiber foods when nausea is prominent may worsen discomfort
Branded medications like Wegovy and Ozempic have received specific FDA approvals for reducing the risk of major cardiovascular events, such as heart attacks or strokes, in certain populations
Advocacy and Policy Pressure The longer-term lever is policy change